aluates Reports

$ 0.0

Automative

Global Soft Capsules Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-19B5833

Global Soft Capsules Drugs Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Soft Capsules Drugs Market Research Report 2025

Code: QYRE-Auto-19B5833

Report

July 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Astrazeneca plc

Boehringer Ingelheim

Vertex

Roche

Novartis

TEVA

Chiesi

Sumitomo Dainippon

Merck

Atrium Innovations

Abbott

Blackmores

The Clorox Company

Nature Made

By-Health

A&Z Pharmaceutical

Soft Capsules Drugs Market Size

The global market for Soft Capsules Drugs was valued at US$ 16000 million in the year 2024 and is projected to reach a revised size of US$ 22410 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Soft Capsules Drugs Market

Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Soft Capsules Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Capsules Drugs.

The Soft Capsules Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soft Capsules Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Soft Capsules Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Soft Capsules Drugs Market Report

Report Metric	Details
Report Name	Soft Capsules Drugs Market
Accounted market size in year	US$ 16000 million
Forecasted market size in 2031	US$ 22410 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Liquid Core Drugs Semi-solid Core Drugs
Segment by Application	Hospital Pharmacy Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi, Sumitomo Dainippon, Merck, Atrium Innovations, Abbott, Blackmores, The Clorox Company, Nature Made, By-health, A&Z Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Capsules Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Soft Capsules Drugs Market growing?

Ans: The Soft Capsules Drugs Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Soft Capsules Drugs Market size in 2031?

Ans: The Soft Capsules Drugs Market size in 2031 will be US$ 22410 million.

Who are the main players in the Soft Capsules Drugs Market report?

Ans: The main players in the Soft Capsules Drugs Market are GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi, Sumitomo Dainippon, Merck, Atrium Innovations, Abbott, Blackmores, The Clorox Company, Nature Made, By-health, A&Z Pharmaceutical

What are the Application segmentation covered in the Soft Capsules Drugs Market report?

Ans: The Applications covered in the Soft Capsules Drugs Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Soft Capsules Drugs Market report?

Ans: The Types covered in the Soft Capsules Drugs Market report are Liquid Core Drugs, Semi-solid Core Drugs

Recommended Reports

Capsules & Gelatin

Pharmaceutical Packaging

Drug Therapy & Disease

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liquid Core Drugs

1.2.3 Semi-solid Core Drugs

1.3 Market by Application

1.3.1 Global Soft Capsules Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Soft Capsules Drugs Market Perspective (2020-2031)

2.2 Global Soft Capsules Drugs Growth Trends by Region

2.2.1 Global Soft Capsules Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Soft Capsules Drugs Historic Market Size by Region (2020-2025)

2.2.3 Soft Capsules Drugs Forecasted Market Size by Region (2026-2031)

2.3 Soft Capsules Drugs Market Dynamics

2.3.1 Soft Capsules Drugs Industry Trends

2.3.2 Soft Capsules Drugs Market Drivers

2.3.3 Soft Capsules Drugs Market Challenges

2.3.4 Soft Capsules Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Soft Capsules Drugs Players by Revenue

3.1.1 Global Top Soft Capsules Drugs Players by Revenue (2020-2025)

3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Soft Capsules Drugs Revenue

3.4 Global Soft Capsules Drugs Market Concentration Ratio

3.4.1 Global Soft Capsules Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs Revenue in 2024

3.5 Global Key Players of Soft Capsules Drugs Head office and Area Served

3.6 Global Key Players of Soft Capsules Drugs, Product and Application

3.7 Global Key Players of Soft Capsules Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Soft Capsules Drugs Breakdown Data by Type

4.1 Global Soft Capsules Drugs Historic Market Size by Type (2020-2025)

4.2 Global Soft Capsules Drugs Forecasted Market Size by Type (2026-2031)

5 Soft Capsules Drugs Breakdown Data by Application

5.1 Global Soft Capsules Drugs Historic Market Size by Application (2020-2025)

5.2 Global Soft Capsules Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Soft Capsules Drugs Market Size (2020-2031)

6.2 North America Soft Capsules Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Soft Capsules Drugs Market Size by Country (2020-2025)

6.4 North America Soft Capsules Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Soft Capsules Drugs Market Size (2020-2031)

7.2 Europe Soft Capsules Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Soft Capsules Drugs Market Size by Country (2020-2025)

7.4 Europe Soft Capsules Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Soft Capsules Drugs Market Size (2020-2031)

8.2 Asia-Pacific Soft Capsules Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Soft Capsules Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Soft Capsules Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Soft Capsules Drugs Market Size (2020-2031)

9.2 Latin America Soft Capsules Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Soft Capsules Drugs Market Size by Country (2020-2025)

9.4 Latin America Soft Capsules Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Soft Capsules Drugs Market Size (2020-2031)

10.2 Middle East & Africa Soft Capsules Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Soft Capsules Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Soft Capsules Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Soft Capsules Drugs Introduction

11.1.4 GSK Revenue in Soft Capsules Drugs Business (2020-2025)

11.1.5 GSK Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Soft Capsules Drugs Introduction

11.2.4 AstraZeneca Revenue in Soft Capsules Drugs Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Soft Capsules Drugs Introduction

11.3.4 Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Vertex

11.4.1 Vertex Company Details

11.4.2 Vertex Business Overview

11.4.3 Vertex Soft Capsules Drugs Introduction

11.4.4 Vertex Revenue in Soft Capsules Drugs Business (2020-2025)

11.4.5 Vertex Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Soft Capsules Drugs Introduction

11.5.4 Roche Revenue in Soft Capsules Drugs Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Soft Capsules Drugs Introduction

11.6.4 Novartis Revenue in Soft Capsules Drugs Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Teva

11.7.1 Teva Company Details

11.7.2 Teva Business Overview

11.7.3 Teva Soft Capsules Drugs Introduction

11.7.4 Teva Revenue in Soft Capsules Drugs Business (2020-2025)

11.7.5 Teva Recent Development

11.8 Chiesi

11.8.1 Chiesi Company Details

11.8.2 Chiesi Business Overview

11.8.3 Chiesi Soft Capsules Drugs Introduction

11.8.4 Chiesi Revenue in Soft Capsules Drugs Business (2020-2025)

11.8.5 Chiesi Recent Development

11.9 Sumitomo Dainippon

11.9.1 Sumitomo Dainippon Company Details

11.9.2 Sumitomo Dainippon Business Overview

11.9.3 Sumitomo Dainippon Soft Capsules Drugs Introduction

11.9.4 Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2020-2025)

11.9.5 Sumitomo Dainippon Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Soft Capsules Drugs Introduction

11.10.4 Merck Revenue in Soft Capsules Drugs Business (2020-2025)

11.10.5 Merck Recent Development

11.11 Atrium Innovations

11.11.1 Atrium Innovations Company Details

11.11.2 Atrium Innovations Business Overview

11.11.3 Atrium Innovations Soft Capsules Drugs Introduction

11.11.4 Atrium Innovations Revenue in Soft Capsules Drugs Business (2020-2025)

11.11.5 Atrium Innovations Recent Development

11.12 Abbott

11.12.1 Abbott Company Details

11.12.2 Abbott Business Overview

11.12.3 Abbott Soft Capsules Drugs Introduction

11.12.4 Abbott Revenue in Soft Capsules Drugs Business (2020-2025)

11.12.5 Abbott Recent Development

11.13 Blackmores

11.13.1 Blackmores Company Details

11.13.2 Blackmores Business Overview

11.13.3 Blackmores Soft Capsules Drugs Introduction

11.13.4 Blackmores Revenue in Soft Capsules Drugs Business (2020-2025)

11.13.5 Blackmores Recent Development

11.14 The Clorox Company

11.14.1 The Clorox Company Company Details

11.14.2 The Clorox Company Business Overview

11.14.3 The Clorox Company Soft Capsules Drugs Introduction

11.14.4 The Clorox Company Revenue in Soft Capsules Drugs Business (2020-2025)

11.14.5 The Clorox Company Recent Development

11.15 Nature Made

11.15.1 Nature Made Company Details

11.15.2 Nature Made Business Overview

11.15.3 Nature Made Soft Capsules Drugs Introduction

11.15.4 Nature Made Revenue in Soft Capsules Drugs Business (2020-2025)

11.15.5 Nature Made Recent Development

11.16 By-health

11.16.1 By-health Company Details

11.16.2 By-health Business Overview

11.16.3 By-health Soft Capsules Drugs Introduction

11.16.4 By-health Revenue in Soft Capsules Drugs Business (2020-2025)

11.16.5 By-health Recent Development

11.17 A&Z Pharmaceutical

11.17.1 A&Z Pharmaceutical Company Details

11.17.2 A&Z Pharmaceutical Business Overview

11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Introduction

11.17.4 A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2020-2025)

11.17.5 A&Z Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GSK

Astrazeneca plc

Boehringer Ingelheim

Vertex

Roche

Novartis

TEVA

Chiesi

Sumitomo Dainippon

Merck

Atrium Innovations

Abbott

Blackmores

The Clorox Company

Nature Made

By-Health

A&Z Pharmaceutical

List of Tables

Table 1. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liquid Core Drugs

Table 3. Key Players of Semi-solid Core Drugs

Table 4. Global Soft Capsules Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Soft Capsules Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Soft Capsules Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Soft Capsules Drugs Market Share by Region (2020-2025)

Table 8. Global Soft Capsules Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Soft Capsules Drugs Market Share by Region (2026-2031)

Table 10. Soft Capsules Drugs Market Trends

Table 11. Soft Capsules Drugs Market Drivers

Table 12. Soft Capsules Drugs Market Challenges

Table 13. Soft Capsules Drugs Market Restraints

Table 14. Global Soft Capsules Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Soft Capsules Drugs Market Share by Players (2020-2025)

Table 16. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2024)

Table 17. Ranking of Global Top Soft Capsules Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Soft Capsules Drugs, Headquarters and Area Served

Table 20. Global Key Players of Soft Capsules Drugs, Product and Application

Table 21. Global Key Players of Soft Capsules Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Soft Capsules Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Soft Capsules Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Soft Capsules Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Soft Capsules Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Soft Capsules Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Soft Capsules Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Soft Capsules Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Soft Capsules Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Soft Capsules Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Soft Capsules Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Soft Capsules Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Soft Capsules Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Soft Capsules Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Soft Capsules Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Soft Capsules Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Soft Capsules Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Soft Capsules Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Soft Capsules Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Soft Capsules Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. GSK Company Details

Table 47. GSK Business Overview

Table 48. GSK Soft Capsules Drugs Product

Table 49. GSK Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 50. GSK Recent Development

Table 51. AstraZeneca Company Details

Table 52. AstraZeneca Business Overview

Table 53. AstraZeneca Soft Capsules Drugs Product

Table 54. AstraZeneca Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 55. AstraZeneca Recent Development

Table 56. Boehringer Ingelheim Company Details

Table 57. Boehringer Ingelheim Business Overview

Table 58. Boehringer Ingelheim Soft Capsules Drugs Product

Table 59. Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 60. Boehringer Ingelheim Recent Development

Table 61. Vertex Company Details

Table 62. Vertex Business Overview

Table 63. Vertex Soft Capsules Drugs Product

Table 64. Vertex Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 65. Vertex Recent Development

Table 66. Roche Company Details

Table 67. Roche Business Overview

Table 68. Roche Soft Capsules Drugs Product

Table 69. Roche Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis Soft Capsules Drugs Product

Table 74. Novartis Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. Teva Company Details

Table 77. Teva Business Overview

Table 78. Teva Soft Capsules Drugs Product

Table 79. Teva Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 80. Teva Recent Development

Table 81. Chiesi Company Details

Table 82. Chiesi Business Overview

Table 83. Chiesi Soft Capsules Drugs Product

Table 84. Chiesi Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 85. Chiesi Recent Development

Table 86. Sumitomo Dainippon Company Details

Table 87. Sumitomo Dainippon Business Overview

Table 88. Sumitomo Dainippon Soft Capsules Drugs Product

Table 89. Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 90. Sumitomo Dainippon Recent Development

Table 91. Merck Company Details

Table 92. Merck Business Overview

Table 93. Merck Soft Capsules Drugs Product

Table 94. Merck Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 95. Merck Recent Development

Table 96. Atrium Innovations Company Details

Table 97. Atrium Innovations Business Overview

Table 98. Atrium Innovations Soft Capsules Drugs Product

Table 99. Atrium Innovations Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 100. Atrium Innovations Recent Development

Table 101. Abbott Company Details

Table 102. Abbott Business Overview

Table 103. Abbott Soft Capsules Drugs Product

Table 104. Abbott Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 105. Abbott Recent Development

Table 106. Blackmores Company Details

Table 107. Blackmores Business Overview

Table 108. Blackmores Soft Capsules Drugs Product

Table 109. Blackmores Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 110. Blackmores Recent Development

Table 111. The Clorox Company Company Details

Table 112. The Clorox Company Business Overview

Table 113. The Clorox Company Soft Capsules Drugs Product

Table 114. The Clorox Company Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 115. The Clorox Company Recent Development

Table 116. Nature Made Company Details

Table 117. Nature Made Business Overview

Table 118. Nature Made Soft Capsules Drugs Product

Table 119. Nature Made Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 120. Nature Made Recent Development

Table 121. By-health Company Details

Table 122. By-health Business Overview

Table 123. By-health Soft Capsules Drugs Product

Table 124. By-health Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 125. By-health Recent Development

Table 126. A&Z Pharmaceutical Company Details

Table 127. A&Z Pharmaceutical Business Overview

Table 128. A&Z Pharmaceutical Soft Capsules Drugs Product

Table 129. A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2020-2025) & (US$ Million)

Table 130. A&Z Pharmaceutical Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Soft Capsules Drugs Picture

Figure 2. Global Soft Capsules Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Soft Capsules Drugs Market Share by Type: 2024 VS 2031

Figure 4. Liquid Core Drugs Features

Figure 5. Semi-solid Core Drugs Features

Figure 6. Global Soft Capsules Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Soft Capsules Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Soft Capsules Drugs Report Years Considered

Figure 11. Global Soft Capsules Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Soft Capsules Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Soft Capsules Drugs Market Share by Region: 2024 VS 2031

Figure 14. Global Soft Capsules Drugs Market Share by Players in 2024

Figure 15. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Soft Capsules Drugs Revenue in 2024

Figure 17. North America Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Soft Capsules Drugs Market Share by Country (2020-2031)

Figure 19. United States Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Soft Capsules Drugs Market Share by Country (2020-2031)

Figure 23. Germany Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Soft Capsules Drugs Market Share by Region (2020-2031)

Figure 31. China Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Soft Capsules Drugs Market Share by Country (2020-2031)

Figure 39. Mexico Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Soft Capsules Drugs Market Share by Country (2020-2031)

Figure 43. Turkey Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Soft Capsules Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. GSK Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 47. AstraZeneca Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 48. Boehringer Ingelheim Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 49. Vertex Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 53. Chiesi Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 54. Sumitomo Dainippon Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 56. Atrium Innovations Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 57. Abbott Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 58. Blackmores Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 59. The Clorox Company Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 60. Nature Made Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 61. By-health Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 62. A&Z Pharmaceutical Revenue Growth Rate in Soft Capsules Drugs Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Soft Capsules Market Research Report 2024

Global Health Supplements Softgel Capsules Market Research Report 2024

Medicinal Gelatin Soft Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Soft Gelatin Capsules Market Research Report 2024

Global Soft Gelatin Capsules Softgels Market Insights Forecast to 2030

Global Bio Reactors and Fermentors Market Research Report 2024

Gel Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Softgel Capsules for Supplements Market Research Report 2025

Softgel Capsule Machinery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Easy Chewable Softgels Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gelatin Based Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global One piece Soft Capsule Market Research Report 2025

Global Animal Source Gelatin Softgels Market Research Report 2025

Global Prefilled Softgel Capsule Market Research Report 2025

Global Softgel Manufacturing Equipment Market Research Report 2025

Global Gelatin Capsule Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Enteric Coated Softgels For Consumer Health Spplements Market Research Report 2024

Global Softgel Encapsulation System Market Research Report 2025

Global Flavor Carriers Market Insights Forecast to 2030

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26D19461

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18S16538

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14W1499

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Y1251

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions